Literature DB >> 3488196

Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

R Labia, M Barthelemy, C B Le Bouguennec, A Buu Hoi-Dang Van.   

Abstract

Branhamella catarrhalis strains resistant to commonly used penicillins, and presently isolated, produce a beta-lactamase. Most of these enzymes are chromosomally mediated, but a plasmid-mediated beta-lactamase has been described (enzyme BRO-1). With reference to isoelectric points, 7 different enzymes have been identified: 6 chromosomally mediated and 1 plasmid-mediated. Nevertheless, they have many common properties, such as being biosynthesised constitutively but with a low level of production. They have a penicillinase-type profile, and are strongly inhibited by clavulanic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488196     DOI: 10.2165/00003495-198600313-00011

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  33 in total

1.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

2.  Beta-lactamase production in commensal Neisseriaceae.

Authors:  P Piot; M Roberts; G Ninane
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

3.  [Branhamella catarrhalis in infectious pathology of the respiratory tract].

Authors:  A Le Faou; A Rio
Journal:  Presse Med       Date:  1983-09-24       Impact factor: 1.228

4.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

Review 5.  Molecular aspects of beta-lactamase inhibition and inactivation by clavulanic acid: a review.

Authors:  R Labia; M Barthélemy; J Peduzzi
Journal:  Drugs Exp Clin Res       Date:  1985

6.  Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors:  A Percival; J E Corkill; J Rowlands; R B Sykes
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

7.  Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors:  G Ninane; J Joly; M Kraytman; P Piot
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

8.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

9.  Influence of beta-lactamase-producing strains of Branhamella catarrhalis and Haemophilus influenzae on certain beta-lactam antibiotics.

Authors:  J Johnsson; J E Brorson
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

10.  Penicillinase-producing Neisseria gonorrhoeae in the Netherlands: epidemiology and genetic and molecular characterization of their plasmids.

Authors:  J D van Embden; B van Klingeren; M Dessens-Kroon; L J van Wijngaarden
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more
  6 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors:  W Cullmann
Journal:  Med Klin (Munich)       Date:  1997-03-15

Review 3.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

4.  Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis.

Authors:  G V Doern; T Tubert
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.

Authors:  G V Doern; T A Tubert
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.